APA (7th ed.) Citation

OY, T., L, T., T, Y., R, X., I, K., M, G., . . . ZA, B. (2022). PD1 Expression in EGFRvIII-Directed CAR T Cell Infusion Product for Glioblastoma Is Associated with Clinical Response. Frontiers in immunology, 13, 872756. https://doi.org/10.3389/fimmu.2022.872756

Chicago Style (17th ed.) Citation

OY, Tang, et al. "PD1 Expression in EGFRvIII-Directed CAR T Cell Infusion Product for Glioblastoma Is Associated with Clinical Response." Frontiers in Immunology 13 (2022): 872756. https://doi.org/10.3389/fimmu.2022.872756.

MLA (9th ed.) Citation

OY, Tang, et al. "PD1 Expression in EGFRvIII-Directed CAR T Cell Infusion Product for Glioblastoma Is Associated with Clinical Response." Frontiers in Immunology, vol. 13, 2022, p. 872756, https://doi.org/10.3389/fimmu.2022.872756.